Patient info

C02A Antiadrenergic agents, centrally acting

ATC group of level 3 – pharmacological subgroup · in plain English: medicines for high blood pressure

This site has the patient leaflet or the SPC of 48 medicines in this group and its subgroups.

Place in the ATC classification

  1. C Cardiovascular system drugs 1,712 medicines
    1. C02 Antihypertensives 133 medicines
      1. C02A Antiadrenergic agents, centrally acting 48 medicines
        1. C02AB Methyldopa, centrally acting adntiadrenergic agents 16 medicines
        2. C02AC Imidazoline receptor agonists 32 medicines

1 more subgroup has no medicine with a leaflet on this site.

Active substances in the group

Medicines in the group and its subgroups

MedicineLegal category
Aldomet tablets 250 mg SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Aldomet tablets 500 mg (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Catapres ampoules 0.15 mg / ml SPC no longer supplied (C02AC01 clonidine) –
Clonidine Hydrochloride 100 microgram film-coated tablets SPC (C02AC01 clonidine) Prescription only (POM)
Clonidine Hydrochloride 100 microgram tablets SPC (C02AC01 clonidine) Prescription only (POM)
Clonidine Hydrochloride 100 micrograms/ 5 ml oral solution SPC (C02AC01 clonidine) Prescription only (POM)
Clonidine Hydrochloride 150 micrograms/ml solution for injection (C02AC01 clonidine) Prescription only (POM)
Clonidine Macure 150 micrograms/ml solution for injection SPC (C02AC01 clonidine) Prescription only (POM)
Guanfacine 2 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine 3 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine 4 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine 5 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine 6 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine 7 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine Crescent 1 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine Crescent 3 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Guanfacine Crescent 4 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Intuniv 1 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Intuniv 3 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Intuniv 4 mg prolonged-release tablets SPC (C02AC02 guanfacine) Prescription only (POM)
Methyldopa 125 mg tablets SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 250 mg tablets SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 250 mg tablets BP SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 250 mg tablets, Medomet 250 mg tablets SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 500 mg film-coated tablets, Aldomet 500 mg film-coated tablets (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 500 mg tablets SPC no longer supplied (C02AB01 methyldopa (levorotatory)) –
Methyldopa 500 mg tablets BP SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa 500 mg tablets, Medomet 500 mg tablets SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa tablets 125 mg SPC no longer supplied (C02AB01 methyldopa (levorotatory)) –
Methyldopa tablets 250 mg SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa tablets 500 mg SPC no longer supplied (C02AB01 methyldopa (levorotatory)) –
Methyldopa tablets BP 125 mg SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa tablets BP 250 mg SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Methyldopa tablets BP 500 mg SPC (C02AB01 methyldopa (levorotatory)) Prescription only (POM)
Moxonidine 0.2 mg film-coated tablets SPC no longer supplied (C02AC05 moxonidine) –
Moxonidine 0.3 mg film-coated tablets SPC no longer supplied (C02AC05 moxonidine) –
Moxonidine 0.4 mg film-coated tablets SPC no longer supplied (C02AC05 moxonidine) –
Moxonidine 200 mcg film-coated tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Moxonidine 200 micrograms tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Moxonidine 300 mcg film-coated tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Moxonidine 300 micrograms tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Moxonidine 400 microgram film-coated tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Moxonidine 400 micrograms tablets SPC (C02AC05 moxonidine) Prescription only (POM)
Physiotens 200 micrograms film-coated tablets (C02AC05 moxonidine) Prescription only (POM)
Physiotens 400 micrograms film-coated tablets (C02AC05 moxonidine) Prescription only (POM)
Physiotens tablets 200 micrograms (C02AC05 moxonidine) Prescription only (POM)
Physiotens tablets 300 micrograms (C02AC05 moxonidine) Prescription only (POM)
Physiotens tablets 400 micrograms SPC (C02AC05 moxonidine) Prescription only (POM)

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group C02A

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.